Cosmetic Botulinum Toxin. Has It Replaced More Invasive Facial Procedures?

Myriam Loyo, Theda C. Kontis

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Botulinum toxin (BoNTA) has become the modern generation's treatment of choice for facial aging. Advanced uses of neurotoxin have treated specific areas of the face, in addition to the glabella, which is the only site for injection approved by the Food and Drug Administration. This article suggests that BoNTA has replaced surgical procedures that treat oral commissures, mild brow ptosis and brow asymmetries, and hypertrophic orbicularis oculi muscles. It is becoming increasingly used for lip asymmetry, platysmal banding, and necklift, although it has not replaced traditional procedures for the correction of these areas.

Original languageEnglish (US)
Pages (from-to)285-298
Number of pages14
JournalFacial plastic surgery clinics of North America
Issue number2
StatePublished - May 2013
Externally publishedYes


  • Botulinum toxin
  • Chemical browlift
  • Hypertrophic orbicularis oculi
  • Liplift
  • Necklift
  • Oral commissure
  • Platysmal banding

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Cosmetic Botulinum Toxin. Has It Replaced More Invasive Facial Procedures?'. Together they form a unique fingerprint.

Cite this